Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Q32 Bio Inc., 3 years.
Q32 Bio Inc.
Director
Stoke Therapeutics Inc.
Director · Interim Executive Chair
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Stoke Therapeutics Inc. | Option exercise | +3,955 | $8.33 | $32,945 |
| Mar 10, 2026 | Stoke Therapeutics Inc. | Open-market sale | −4,355 | $40.00 | $174,200 |
| Mar 25, 2024 | Q32 Bio Inc. | Option exercise | +1,095 | — | — |
| Mar 25, 2024 | Q32 Bio Inc. | Open-market sale | −265 | $24.20 | $6,413 |
| Feb 13, 2024 | Stoke Therapeutics Inc. | Option exercise | +31,739 | $2.19 | $69,508 |
| Jan 9, 2024 | Q32 Bio Inc. | Open-market sale | −13,037 | $0.57 | $7,431 |
| Jan 1, 2024 | Q32 Bio Inc. | Option exercise | +14,280 | — | — |
| Jan 1, 2024 | Q32 Bio Inc. | Option exercise | +19,140 | — | — |
| Jan 9, 2023 | Q32 Bio Inc. | Open-market sale | −10,616 | $1.39 | $14,756 |
| Jan 1, 2023 | Q32 Bio Inc. | Option exercise | +13,860 | — | — |
| Jan 1, 2023 | Q32 Bio Inc. | Option exercise | +19,140 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.